悦芽生物 (837323.OC)

+ 收藏

现金流量表(悦芽生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 41,816,697.5086,635,651.4064,113,489.22135,199,093.8862,851,566.78
 收到其他与经营活动有关的现金(元) 308,895.76501,118.2825,872.5574,847.6037,808.45
 经营活动现金流入小计(元) 42,125,593.2687,136,769.6864,139,361.77135,273,941.4862,889,375.23
 购买商品、接受劳务支付的现金(元) 28,715,104.9070,050,878.6051,695,548.17124,149,870.8952,123,260.82
 支付给职工以及为职工支付的现金(元) 3,055,418.604,992,186.432,626,756.245,068,018.452,700,151.09
 支付的各项税费(元) 517,498.771,466,474.09475,394.472,534,664.842,594,946.77
 支付其他与经营活动有关的现金(元) 3,814,970.185,680,370.393,016,006.237,174,266.405,073,652.73
 经营活动现金流出小计(元) 36,102,992.4582,189,909.5157,813,705.11138,926,820.5862,492,011.41
 经营活动产生的现金流量净额(元) 6,022,600.814,946,860.176,325,656.66-3,652,879.10397,363.82
二、投资活动产生的现金流量
 收回投资收到的现金(元) 26,929,213.3643,530,000.0016,530,000.0045,900,000.0014,300,000.00
 取得投资收益收到的现金(元) 36,012.08-67,619.17-124,341.86
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 41,000.00550.00-700.00-
 投资活动现金流入小计(元) 27,006,225.4443,530,550.0016,597,619.1745,900,700.0014,424,341.86
 购建固定资产、无形资产和其他长期资产支付的现金(元) 32,025.6849,166.1124,583.9121,648.0020,460.37
 投资支付的现金(元) 27,243,621.1850,500,000.0024,567,619.1743,650,002.0018,474,342.86
 投资活动现金流出小计(元) 27,275,646.8650,549,166.1124,592,203.0843,671,650.0018,494,803.23
 投资活动产生的现金流量净额(元) -269,421.42-7,018,616.11-7,994,583.912,229,050.00-4,070,461.37
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) ---1,950,000.00-
  其中:子公司吸收少数股东投资收到的现金(元) ---1,950,000.00-
 取得借款收到的现金(元) -7,400,000.003,400,000.0017,600,000.008,600,000.00
 筹资活动现金流入小计(元) -7,400,000.003,400,000.0019,550,000.008,600,000.00
 偿还债务支付的现金(元) 5,950,000.006,052,500.002,397,500.0015,330,000.00715,000.00
 分配股利、利润或偿付利息支付的现金(元) 208,114.72457,438.94215,415.97633,555.42206,365.28
 筹资活动现金流出小计(元) 6,158,114.726,509,938.942,612,915.9715,963,555.42921,365.28
 筹资活动产生的现金流量净额(元) -6,158,114.72890,061.06787,084.033,586,444.587,678,634.72
五、现金及现金等价物净增加额(元) -404,935.33-1,181,694.88-881,843.222,162,615.484,005,537.17
 加:期初现金及现金等价物余额(元) 2,002,790.463,184,485.343,184,485.341,021,869.861,021,869.86
 期末现金及现金等价物余额(元) 1,597,855.132,002,790.462,302,642.123,184,485.345,027,407.03
补充资料:
 净利润(元) -460,641.93-1,625,999.23-248,324.75-1,454,032.70-889,410.19
 资产减值准备(元) -163,325.83-66,572.67-307,963.4185,737.75-25,413.38
 固定资产和投资性房地产折旧(元) 13,240.5323,764.8111,379.1419,748.7010,211.46
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 13,240.5323,764.8111,379.1419,748.7010,211.46
 无形资产摊销(元) 1,018.862,037.741,018.864,839.622,122.65
 长期待摊费用摊销(元) 10,091.5510,351.275,859.1320,460.3722,305.67
 处置固定资产、无形资产和其他长期资产的损失(元) -29,080.68-87.46--70.07-
 财务费用(元) 200,514.99457,905.01214,684.14635,879.50209,319.73
 投资损失(元) -36,012.08-172,201.37-67,619.17-364,349.85131,339.83
 递延所得税(元) 8,287.728,863.7315,045.987,330.6121,383.56
  其中:递延所得税资产减少(元) 8,287.728,863.7315,045.987,330.6121,383.56
 存货的减少(元) 597,592.98-1,705,216.98-2,665,681.431,631,089.94580,238.63
 经营性应收项目的减少(元) 6,926,344.874,341,142.847,918,917.57-2,394,662.931,326,795.71
 经营性应付项目的增加(元) -1,045,430.173,672,872.481,448,340.60-1,844,850.04-991,529.85
 现金的期末余额(元) 1,597,855.132,002,790.462,302,642.123,184,485.345,027,407.03
 减:现金的期初余额(元) 2,002,790.463,184,485.343,184,485.341,021,869.861,021,869.86
 现金及现金等价物的净增加额(元) -404,935.33-1,181,694.88-881,843.222,162,615.484,005,537.17
公告日期 2024-08-072024-04-252023-08-172023-04-212022-08-18
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院